- Home
- / Anxo Pharmaceutical
Anxo Pharmaceutical
Stock Price
NT$32
2024-10-29
Market Capitalization
NT$1.8 B
2024-10-29
Revenue
NT$895.3 M
FY, 2024
Anxo Pharmaceutical Summary
Company Summary
- Overview
- Anxo Pharmaceutical is a manufacturer and supplier of pharmaceutical products. It offers prescription drugs in therapeutic areas such as cardiovascular, metabolism, diabetes, gastroenterology, respiratory, anti-infection, dermatology, nephrology, etc.
- Type
- Public
- Status
- Active
- Founded
- 2003
- HQ
- TW | view all locations
- Website
- https://www.anxo.com.tw
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Taipei City HQ
Taiwan
No. 2, Nanjing E Rd, Neihu District
Anxo Pharmaceutical Financials
Summary Financials
- Revenue (H1, 2025)
- NT$402.8M
- Gross profit (H1, 2025)
- NT$181.0M
- Net income (H1, 2025)
- (NT$21.4M)
- Cash (H1, 2025)
- NT$314.3M
- EBIT (H1, 2025)
- (NT$21.7M)
- Enterprise value
- $2.2B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026